Aclaris Therapeutics, Inc. (LON:0H8T)
2.495
-0.040 (-1.58%)
At close: Nov 3, 2025
Aclaris Therapeutics Employees
As of December 31, 2024, Aclaris Therapeutics had 64 total employees, including 61 full-time and 3 part-time employees. The number of employees decreased by 27 or -29.67% compared to the previous year.
Employees
64
Change (1Y)
-27
Growth (1Y)
-29.67%
Revenue / Employee
194.51K GBP
Profits / Employee
-1.56M GBP
Market Cap
210.97M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 64 | -27 | -29.67% |
| Dec 31, 2023 | 91 | -14 | -13.33% |
| Dec 31, 2022 | 105 | 28 | 36.36% |
| Dec 31, 2021 | 77 | 17 | 28.33% |
| Dec 31, 2020 | 60 | -17 | -22.08% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| Spire Healthcare Group | 15,703 |
| ConvaTec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| Genus | 3,190 |
Aclaris Therapeutics News
- 5 days ago - Aclaris Therapeutics to Participate in Three November Healthcare Conferences - GlobeNewsWire
- 20 days ago - Aclaris Therapeutics, Inc. - Special Call - Seeking Alpha
- 20 days ago - Aclaris Therapeutics, Inc. (ACRS) Special Call - Slideshow - Seeking Alpha
- 4 weeks ago - Aclaris Therapeutics to Host In-Person and Webcast R&D Day, “Patient Focused Innovation: Addressing Gaps in Immuno-Inflammatory Markets”, in New York on October 14, 2025 - GlobeNewsWire
- 7 weeks ago - Aclaris Therapeutics Announces Late-Breaking Abstract and Oral Presentation On ATI-2138 Phase 2a Results at the 2025 European Academy of Dermatology and Venereology (EADV) Congress - GlobeNewsWire
- 2 months ago - Aclaris Therapeutics to Participate in Two September Healthcare Conferences - GlobeNewsWire
- 3 months ago - Aclaris Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 3 months ago - Aclaris Therapeutics Stock Spikes In After‑Hours Session Following Major Announcement - Benzinga